Literature DB >> 1538710

Time-, voltage-, and state-dependent block by quinidine of a cloned human cardiac potassium channel.

J Snyders1, K M Knoth, S L Roberds, M M Tamkun.   

Abstract

The interaction of quinidine with a cloned human cardiac potassium channel (HK2) expressed in a stable mouse L cell line was studied using the whole-cell tight-seal voltage-clamp technique. Quinidine (20 microM) did not affect the initial sigmoidal activation time course of the current. However, it reduced the peak current and induced a subsequent decline, with a time constant of 8.2 +/- 0.8 msec, to 28 +/- 6% of control (at +60 mV). The concentration dependence of HK2 block at +60 mV yielded an apparent KD of 6 microM and a Hill coefficient of 0.9. The degree of block was voltage dependent. Block increased from 0.60 +/- 0.09 at 0 mV to 0.72 +/- 0.06 at +60 mV with 20 microM quinidine and from 0.39 +/- 0.20 to 0.48 +/- 0.16 with 6 microM. Paired analysis in seven experiments with 20 microM quinidine indicated that the voltage-dependent increase in block was significant (difference, 12 +/- 4%; p less than 0.001). This voltage dependence was described by an equivalent electrical distance delta of 0.19 +/- 0.02, which suggested that at the binding site quinidine experienced 19% of the applied transmembrane electrical field, referenced to the inner surface. Quinidine reduced the tail current amplitude and slowed the time course relative to control, resulting in a "crossover" phenomenon. These data indicate that 1) the charged form of quinidine blocks the HK2 channel after it opens, 2) binding occurs within the transmembrane electrical field (probably in or near the ion permeation pathway), and 3) unbinding is required before the channel can close.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1538710

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  56 in total

Review 1.  Antiarrhythmics--from cell to clinic: past, present, and future.

Authors:  J C Hancox; K C Patel; J V Jones
Journal:  Heart       Date:  2000-07       Impact factor: 5.994

2.  Quinine blocks specific gap junction channel subtypes.

Authors:  M Srinivas; M G Hopperstad; D C Spray
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

3.  Gating charge and ionic currents associated with quinidine block of human Kv1.5 delayed rectifier channels.

Authors:  D Fedida
Journal:  J Physiol       Date:  1997-03-15       Impact factor: 5.182

4.  Blockade of HERG human K+ channels and IKr of guinea-pig cardiomyocytes by the antipsychotic drug clozapine.

Authors:  So-Young Lee; Young-Jin Kim; Kyong-Tai Kim; Han Choe; Su-Hyun Jo
Journal:  Br J Pharmacol       Date:  2006-04-24       Impact factor: 8.739

5.  Kv1.4 channel block by quinidine: evidence for a drug-induced allosteric effect.

Authors:  Shimin Wang; Michael J Morales; Yu-Jie Qu; Glenna C L Bett; Harold C Strauss; Randall L Rasmusson
Journal:  J Physiol       Date:  2003-01-15       Impact factor: 5.182

6.  Effects of propafenone on K currents in human atrial myocytes.

Authors:  A Seki; N Hagiwara; H Kasanuki
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

7.  Ligand binding to the voltage-gated Kv1.5 potassium channel in the open state--docking and computer simulations of a homology model.

Authors:  Martin Andér; Victor B Luzhkov; Johan Aqvist
Journal:  Biophys J       Date:  2007-09-28       Impact factor: 4.033

8.  Modeling the effect of Kv1.5 block on the canine action potential.

Authors:  Joachim Almquist; Mikael Wallman; Ingemar Jacobson; Mats Jirstrand
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

9.  Antiarrhythmic drug-induced internalization of the atrial-specific k+ channel kv1.5.

Authors:  Sarah M Schumacher; Dyke P McEwen; Lian Zhang; Kristin L Arendt; Kristin M Van Genderen; Jeffrey R Martens
Journal:  Circ Res       Date:  2009-05-14       Impact factor: 17.367

10.  Potent block of Cx36 and Cx50 gap junction channels by mefloquine.

Authors:  Scott J Cruikshank; Matthew Hopperstad; Meg Younger; Barry W Connors; David C Spray; Miduturu Srinivas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.